Insider · CIK 0001193743
David I. Chemerow
Files at AIM (AIM ImmunoTech Inc.), RIBT (RiceBran Technologies). First filing -, latest -.
In brief
David I. Chemerow files SEC Form 4 as director at AIM (AIM ImmunoTech Inc.), and also at RIBT (RiceBran Technologies). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David I. Chemerow has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | AIM AIM ImmunoTech Inc. | CConversion Common Stock | +25,000 | $0.00 | $0 | 28,441 | Mar 16, 2026 |
| Mar 12, 2026 | AIM AIM ImmunoTech Inc. | CConversion Series G Convertible Prefered Stockderivative | -25 | $0.00 | $0 | 0 | Mar 16, 2026 |
| Mar 6, 2026 | AIM AIM ImmunoTech Inc. | JOther Series G Convertible Preferred Stockderivative | +25 | $25,000.00 | $625k | 25 | Mar 10, 2026 |
| Mar 6, 2026 | AIM AIM ImmunoTech Inc. | JOther Class G Warrantsderivative | +50,000 | $0.00 | $0 | 50,000 | Mar 10, 2026 |
| Feb 5, 2026 | AIM AIM ImmunoTech Inc. | AGrant or award Common Stockindirect: The David I Chemerow 1992 Trust | +2,800 | $1.23 | $3,444 | 3,441 | Feb 6, 2026 |
| Mar 14, 2025 | AIM AIM ImmunoTech Inc. | AGrant or award Common Stock | +44,899 | $0.12 | $5,208 | 64,189 | Mar 18, 2025 |
| Feb 28, 2025 | AIM AIM ImmunoTech Inc. | AGrant or award Common Stock | +19,290 | $0.14 | $2,604 | 19,290 | Mar 4, 2025 |
| Dec 31, 2023 | RIBT RiceBran Technologies | AGrant or award Deferred Stock Unitsderivative | +65,218 | $0.00 | $0 | 198,545 | Jan 8, 2024 |
Questions about David I. Chemerow
Answered from the filings on this page, as of the latest one.
Is David I. Chemerow buying or selling?
David I. Chemerow has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David I. Chemerow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David I. Chemerow has 0.
Where does David I. Chemerow file Form 4?
David I. Chemerow has filed Form 4 at AIM (AIM ImmunoTech Inc.); RIBT (RiceBran Technologies). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.